[go: up one dir, main page]

GB201304250D0 - Compound - Google Patents

Compound

Info

Publication number
GB201304250D0
GB201304250D0 GBGB1304250.2A GB201304250A GB201304250D0 GB 201304250 D0 GB201304250 D0 GB 201304250D0 GB 201304250 A GB201304250 A GB 201304250A GB 201304250 D0 GB201304250 D0 GB 201304250D0
Authority
GB
United Kingdom
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1304250.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coegin Pharma AS
Original Assignee
Avexxin AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avexxin AS filed Critical Avexxin AS
Priority to GBGB1304250.2A priority Critical patent/GB201304250D0/en
Publication of GB201304250D0 publication Critical patent/GB201304250D0/en
Priority to CN201910260344.9A priority patent/CN110128370A/en
Priority to CN201480010566.0A priority patent/CN105102438B/en
Priority to EP14702520.9A priority patent/EP2951164B1/en
Priority to PCT/EP2014/051655 priority patent/WO2014118195A1/en
Priority to AU2014211489A priority patent/AU2014211489A1/en
Priority to CA2899137A priority patent/CA2899137C/en
Priority to KR1020157023249A priority patent/KR102268357B1/en
Priority to JP2015554204A priority patent/JP6371312B2/en
Priority to US14/764,509 priority patent/US20150376161A1/en
Priority to AU2016266022A priority patent/AU2016266022B2/en
Priority to US15/789,834 priority patent/US10259801B2/en
Priority to JP2018131540A priority patent/JP2018184429A/en
Priority to AU2018208695A priority patent/AU2018208695A1/en
Priority to US16/663,931 priority patent/US11034666B2/en
Priority to US17/344,605 priority patent/US11691959B2/en
Ceased legal-status Critical Current

Links

GBGB1304250.2A 2013-01-29 2013-03-08 Compound Ceased GB201304250D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB1304250.2A GB201304250D0 (en) 2013-03-08 2013-03-08 Compound
US14/764,509 US20150376161A1 (en) 2013-01-29 2014-01-28 Antiiflammatory and antitumor 2-oxothiazoles abd 2-oxothiophenes compounds
CA2899137A CA2899137C (en) 2013-01-29 2014-01-28 Antiinflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds
JP2015554204A JP6371312B2 (en) 2013-01-29 2014-01-28 Anti-inflammatory and anti-tumor 2-oxothiazole compounds and 2-oxothiophene compounds
EP14702520.9A EP2951164B1 (en) 2013-01-29 2014-01-28 Antiinflammatory and antitumor 2-oxothiazoles compounds
PCT/EP2014/051655 WO2014118195A1 (en) 2013-01-29 2014-01-28 Antiinflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds
AU2014211489A AU2014211489A1 (en) 2013-01-29 2014-01-28 Antiinflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds
CN201910260344.9A CN110128370A (en) 2013-01-29 2014-01-28 Anti-inflammatory and antitumor 2- oxothiazoiium class and 2- oxo thiophenes
KR1020157023249A KR102268357B1 (en) 2013-01-29 2014-01-28 Antiinflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds
CN201480010566.0A CN105102438B (en) 2013-01-29 2014-01-28 Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes
AU2016266022A AU2016266022B2 (en) 2013-01-29 2016-11-30 Antiinflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds
US15/789,834 US10259801B2 (en) 2013-01-29 2017-10-20 Anti-inflammatory and antitumor 2-oxothiazoles ABD 2-oxothiophenes compounds
JP2018131540A JP2018184429A (en) 2013-01-29 2018-07-11 Antiiflammatory and antitumor 2-oxothiazole compounds and 2-oxothiophene compounds
AU2018208695A AU2018208695A1 (en) 2013-01-29 2018-07-26 Antiinflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds
US16/663,931 US11034666B2 (en) 2013-01-29 2019-10-25 Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds
US17/344,605 US11691959B2 (en) 2013-01-29 2021-06-10 Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1304250.2A GB201304250D0 (en) 2013-03-08 2013-03-08 Compound

Publications (1)

Publication Number Publication Date
GB201304250D0 true GB201304250D0 (en) 2013-04-24

Family

ID=48189631

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1304250.2A Ceased GB201304250D0 (en) 2013-01-29 2013-03-08 Compound

Country Status (1)

Country Link
GB (1) GB201304250D0 (en)

Similar Documents

Publication Publication Date Title
IL249518B (en) Trk-inhibiting compound
IL243592A0 (en) Cyanotriazole compounds
GB201311891D0 (en) Novel compound
AP2015008713A0 (en) Tetrahydropyrrolothiazine compounds
GB201302927D0 (en) Compounds
SG11201600759XA (en) Novel quinoline-substituted compound
GB201302368D0 (en) Compound
ZA201507044B (en) Pyridinylpyrazoloquinoline compound
GB201319363D0 (en) Compounds
AP3850A (en) Azetidinyloxyphenylpyrrolidine compounds
EP2948457A4 (en) Compounds
GB201306794D0 (en) Compounds
GB201307331D0 (en) Compound
IL240964A0 (en) Azetidinyloxyphenylpyrrolidine compounds
GB201408643D0 (en) Compound
GB201310460D0 (en) Compounds
GB201322438D0 (en) Compound
GB201315772D0 (en) Compound
GB201305634D0 (en) Compound
GB201304250D0 (en) Compound
GB201301585D0 (en) Compound
GB201303572D0 (en) New Compound
GB201321283D0 (en) Compounds
GB201318323D0 (en) Compounds
GB201317118D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)